Clinical Trial Update: Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study comparing paclitaxel/carboplatin/gemcitabine versus gemcitabine/vinorelbine in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED